This recent study explores the use of dehydrated amniotic membrane (DHAM) as a treatment for hard-to-heal wounds, specifically diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). Conducted across multiple U.S. clinics, the research aimed to evaluate DHAM's effectiveness in reducing wound size for patients whose wounds had not responded to standard treatments.
Key Findings:
Significant Wound Reduction: The study reports a 50% reduction in wound size after approximately two DHAM applications. Most wounds showed noticeable improvement after the first application, with DFUs and VLUs responding at slightly different rates.
Enhanced Healing Potential: DHAM treatments led to faster wound reduction than
standard care alone, suggesting that it may serve as an effective intervention for chronic
wounds resistant to other methods.
Safety and No Adverse Events: No adverse events were reported during DHAM use,
underscoring its safety and potential as a low-risk option for patients with chronic,
treatment-resistant wounds. Implications: The findings support DHAM’s role in promoting healing in chronic wound care, potentially reducing healthcare costs and clinic visits while improving patients' quality of life. This research adds to the evidence for regenerative therapies in wound management, highlighting DHAM’s capacity to aid in wound closure through anti-inflammatory and anti-microbial effects. Further research with larger samples and randomized controls could expand understanding of DHAM’s mechanisms and its use across wound types. At WoundFree, we’re committed to raising awareness about the importance of early detection and proper wound care. For those at risk, regular screening and preventive measures can make a profound difference.
Comentários